Close
Close

Peptide S598 Q600Y

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

JHMV is a member of the same group of coronaviruses as two pathogenic human coronaviruses associated with severe respiratory disease. The CD8 T cell response to JHMV in C57BL/6 (B6) mice is directed at two epitopes, spanning residues 510–518 and 598–605 of the surface glycoprotein (CSLWNGPHL, S510, H-2Db–restricted and RCQIFANI, S598, H-2Kb–restricted). Epitope S510 is immunodominant, induces a high–functional avidity response, and in some settings undergoes mutation as part of viral evasion of the T cell response. Epitope S598 is subdominant and binds with lower affinity to the MHCI molecule than peptide S510. Furthermore, the low–functional avidity response to epitope S598 is unable to protect mice after infection with virus mutated in S510. With the goal of enhancing the S598-specific response, it was optimized peptide binding to Kb by changing a secondary anchor residue at position three of the epitope from Gln to Tyr to match the consensus motif for Kb binding (RCYIFANI; Q600Y). The modified peptide enhanced the stability of pMHCI and induced CD8 T cells with higher functional avidity toward the native form of the S598 epitope. A substantial fraction (∼35%) of the responding T cells recognized only the variant Q600Y epitope. This level of cross-reactivity would be unsuitable in a clinical setting because part of the T cell response would be ineffectual (i.e., these T cells would recognize only the heteroclitic peptide and would not contribute to a protective immune response) and could potentially recognize a self-epitope.

  • TCR Vector Products

  • TCR Cell Products

  • TCR Viral Particles

Loading...
  • TCR Clone:
  • Host Species:
  • Epitope:
  • Allele:
  • Vector Type:
CAT Product Name Target Species TCR Clone Host Species Epitope Allele Vector Type Inquiry & Datasheet
TCR-YC0957 Mouse anti-Peptide S598 Q600Y T cell receptor (YC44), pCDTCR1 YC44 Mouse RCYIFANI H2-Kᵇ Lentiviral vector   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.
Copyright © 2024 Creative Biolabs. All Rights Reserved
Cart
    Go to checkout